Climb Bio, Inc. (CLYM) Form SCHEDULE 13D/A — Nov 9, 2026
RA Capital Management and affiliates (Peter Kolchinsky, Rajeev Shah) filed Amendment No. 11 to their Schedule 13D on Climb Bio (CLYM), reporting beneficial ownership of 23,941,277 shares, or 33% of the class, based on 58,738,178 shares outstanding as of October 30, 2026. The amendment explicitly states the filing is to reflect a change in the ownership percentage due to an increase in the issuer's outstanding shares — not any acquisition or disposition by the RA Capital group. A beneficial ownership blocker in the group's pre-funded warrants caps exercise at a 33.0% ownership threshold.
Key figures
- Shares Outstanding
- 58738178
- Ownership percent
- 33%
- Celebi option shares
- 70284
- Nexus fund iii percent
- 6.3%
- Option exercise prices
- ["$3.46","$3.00","$7.89","$1.29"]
- Healthcare fund percent
- 24.4%
- Levin options exercised
- 70000
- Pre funded warrant shares
- 22546000
- Celebi option exercise price
- $13.36
- Beneficial ownership blocker cap
- 33.0%
- Aggregate shares beneficially owned
- 23941277
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.